FDA grants priority review Elite Pharmaceuticals’ SequestOX NDA
The FDA has set a target action date under the Prescription Drug User Fee Act ("PDUFA") of July 14, 2016. SequestOxTM is an immediate-release Oxycodone Hydrochloride containing sequestered
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.